Meihua Bao

3.7k total citations · 2 hit papers
119 papers, 2.7k citations indexed

About

Meihua Bao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Meihua Bao has authored 119 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 20 papers in Cancer Research and 17 papers in Immunology. Recurrent topics in Meihua Bao's work include Cancer-related molecular mechanisms research (16 papers), Circular RNAs in diseases (11 papers) and MicroRNA in disease regulation (9 papers). Meihua Bao is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), Circular RNAs in diseases (11 papers) and MicroRNA in disease regulation (9 papers). Meihua Bao collaborates with scholars based in China, Italy and Canada. Meihua Bao's co-authors include Hong‐Hao Zhou, Zhong‐Ping Feng, Binsheng He, Hong‐Shuo Sun, Liang Tang, Shuzhen Zhu, Vivian Szeto, Yijia Lou, Xiao-Ya Lou and Jianming Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Water Research.

In The Last Decade

Meihua Bao

107 papers receiving 2.7k citations

Hit Papers

Exploring the causal rela... 2024 2026 2024 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meihua Bao China 31 1.2k 716 286 191 164 119 2.7k
Xiaowei Wang China 32 1.5k 1.2× 562 0.8× 184 0.6× 215 1.1× 217 1.3× 169 3.1k
Yujie Huang China 31 1.8k 1.5× 660 0.9× 392 1.4× 204 1.1× 279 1.7× 112 3.3k
Dandan Wu China 19 1.2k 1.0× 427 0.6× 261 0.9× 184 1.0× 170 1.0× 33 2.3k
Jin Ren China 34 1.6k 1.4× 894 1.2× 219 0.8× 305 1.6× 158 1.0× 138 3.5k
Bing Liu China 27 1.7k 1.4× 1.0k 1.4× 240 0.8× 201 1.1× 234 1.4× 91 3.9k
Lili Xu China 34 2.2k 1.9× 548 0.8× 455 1.6× 161 0.8× 155 0.9× 148 3.9k
Tong Zhao China 34 1.4k 1.1× 571 0.8× 150 0.5× 239 1.3× 363 2.2× 180 3.6k
Rong Li China 30 1.2k 1.0× 311 0.4× 300 1.0× 302 1.6× 253 1.5× 98 3.1k
Wei Pei China 28 1.5k 1.3× 272 0.4× 209 0.7× 252 1.3× 169 1.0× 108 3.0k
Yunxia Li China 32 1.1k 0.9× 260 0.4× 217 0.8× 362 1.9× 161 1.0× 155 3.1k

Countries citing papers authored by Meihua Bao

Since Specialization
Citations

This map shows the geographic impact of Meihua Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meihua Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meihua Bao more than expected).

Fields of papers citing papers by Meihua Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meihua Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meihua Bao. The network helps show where Meihua Bao may publish in the future.

Co-authorship network of co-authors of Meihua Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Meihua Bao. A scholar is included among the top collaborators of Meihua Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meihua Bao. Meihua Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Nan, Meihua Bao, Yimin Li, et al.. (2025). Exploration of the primary antibiofilm substance and mechanism employed by Lactobacillus salivarius ATCC 11741 to inhibit biofilm of Streptococcus mutans. Frontiers in Cellular and Infection Microbiology. 15. 1535539–1535539.
3.
Han, Li, Shuling Xu, Rumeng Chen, et al.. (2025). Causal associations between HbA1c and multiple diseases unveiled through a Mendelian randomization phenome-wide association study in East Asian populations. Medicine. 104(11). e41861–e41861. 5 indexed citations
4.
Ding, Yining, Shuling Xu, Rumeng Chen, et al.. (2025). Causal associations of self-reported walking pace with respiratory diseases: A Mendelian randomization analysis. Medicine. 104(11). e41746–e41746. 5 indexed citations
5.
Dou, Peng, Meihua Bao, Yanli Li, et al.. (2025). Laser capture microdissection-assisted gas chromatography–triple-quadruple mass spectrometry for spatial metabolic profiling of esophageal squamous cell carcinoma. Journal of Pharmaceutical and Biomedical Analysis. 265. 117036–117036. 1 indexed citations
6.
Cao, Danfeng, Xinyu Zhou, Qian Guo, et al.. (2024). Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy. Biomarker Research. 12(1). 142–142. 30 indexed citations
7.
Jiang, Yan, Rumeng Chen, Shuling Xu, et al.. (2024). Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a Mendelian randomization study. Frontiers in Endocrinology. 14. 1321576–1321576. 38 indexed citations breakdown →
8.
Zhou, Yi, et al.. (2024). Arecoline inhibits the growth of Spodoptera litura by inducing intestinal metabolic dysfunction. Pesticide Biochemistry and Physiology. 204. 106044–106044.
9.
Lu, Jiao, Zhen Guo, Wei Tao Huang, et al.. (2023). Peptide-graphene logic sensing system for dual-mode detection of exosomes, molecular information processing and protection. Talanta. 267. 125261–125261. 8 indexed citations
10.
Cheng, Mengting, Qin Cao, Kening Li, et al.. (2023). Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder. Journal of Pharmaceutical and Biomedical Analysis. 240. 115937–115937. 49 indexed citations
11.
Sun, Zhiyong, et al.. (2023). Role of ferroptosis in fibrosis diseases. The American Journal of the Medical Sciences. 366(2). 87–95. 10 indexed citations
12.
Wang, Nan, et al.. (2022). Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer. Molecular Omics. 19(3). 238–251. 15 indexed citations
13.
Bao, Meihua, Qiao‐Li Lv, Haigang Li, et al.. (2020). A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2/STAT1 Pathway. Mediators of Inflammation. 2020. 1–9. 5 indexed citations
14.
Wu, Lei, et al.. (2019). Pregnancy outcome of recurrent spontaneous abortion in Wilson’s disease after decoppering therapy. Clinical and Experimental Obstetrics & Gynecology. 46(4). 626–629. 1 indexed citations
15.
Xiang, Ju, Hui‐Jia Li, Zhan Bu, et al.. (2018). Critical analysis of (Quasi-)Surprise for community detection in complex networks. Scientific Reports. 8(1). 14459–14459. 8 indexed citations
16.
Li, Jianming, Liang Tang, Yan Wang, et al.. (2017). Genetic Associations and Interactions Between the NR3C1 ( GR ) and NR3C2 ( MR ) Genes and Aggressive Behavior in a Central South Chinese Han Population. Genetic Testing and Molecular Biomarkers. 21(8). 497–505. 5 indexed citations
17.
Turlova, Ekaterina, Feiya Li, Meihua Bao, et al.. (2017). Transient receptor potential melastatin 2 channels (TRPM2) mediate neonatal hypoxic-ischemic brain injury in mice. Experimental Neurology. 296. 32–40. 49 indexed citations
18.
Zheng-xiang, Ning, et al.. (2012). Genetic variation at the TVB locus in Chinese native chicken breeds.. Journal of Animal and Veterinary Advances. 11(22). 4226–4229. 2 indexed citations
19.
20.
Bao, Meihua & Yijia Lou. (2006). Flavonoids From Seabuckthorn Protect Endothelial Cells (EA.hy926) From Oxidized Low-density Lipoprotein Induced Injuries Via Regulation of LOX-1 and eNOS Expression. Journal of Cardiovascular Pharmacology. 48(1). 834–841. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026